News
TXG
15.48
+3.13%
0.47
Trump's Unusual Pick for NIH Director May Be a Win for These Stocks
Barron‘s · 1d ago
Weekly Report: what happened at TXG last week (1118-1122)?
Weekly Report · 3d ago
If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Barron‘s · 11/20 20:29
Weekly Report: what happened at TXG last week (1111-1115)?
Weekly Report · 11/18 09:20
Life sciences stocks viewed positively at TD Cowen despite post-election weakness
Seeking Alpha · 11/15 20:55
Relative Strength Alert For 10x Genomics
NASDAQ · 11/14 21:46
Ray Dalio's Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?
Benzinga · 11/14 14:10
Surprising Analyst 12-Month Target For FXH
NASDAQ · 11/13 12:03
ARKK's holdings ranked by SA Quant Grades
Seeking Alpha · 11/12 19:21
Weekly Report: what happened at TXG last week (1104-1108)?
Weekly Report · 11/11 09:22
Weekly Report: what happened at TXG last week (1028-1101)?
Weekly Report · 11/04 09:23
10x Genomics Price Target Cut to $19.00/Share From $21.00 by Barclays
Dow Jones · 11/01 13:55
10x Genomics Is Maintained at Overweight by Barclays
Dow Jones · 11/01 13:55
Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $19
Benzinga · 11/01 13:45
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts
Simply Wall St · 11/01 13:38
10x Genomics price target lowered to $19 from $21 at Barclays
TipRanks · 11/01 09:35
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), 10x Genomics (TXG) and Bicycle Therapeutics (BCYC)
TipRanks · 11/01 07:30
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Benzinga · 10/31 19:23
TechBio Startup Cure51 Selects 10x Genomics Visium HD For New Drug Discovery Initiative; Cure51 Plans To Analyze More Than 1,000 Tumor Samples From Exceptional Cancer Survivors
Benzinga · 10/31 12:22
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), 10x Genomics (TXG) and Chugai Pharmaceutical Co (OtherCHGCF)
TipRanks · 10/31 12:21
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.